$1.76 EPS Expected for Express Scripts Holding Company (ESRX)

April 20, 2018 - By Hazel Jackson

Express Scripts Holding Company (NASDAQ:ESRX) LogoInvestors sentiment increased to 0.69 in 2017 Q4. Its up 0.07, from 0.62 in 2017Q3. It increased, as 68 investors sold Express Scripts Holding Company shares while 407 reduced holdings. 111 funds opened positions while 216 raised stakes. 479.40 million shares or 1.52% less from 486.80 million shares in 2017Q3 were reported.
Security Trust accumulated 5,774 shares. Bb&T Corporation owns 60,303 shares for 0.08% of their portfolio. Old Mutual Customised Solutions (Proprietary) Ltd owns 16,355 shares. The Michigan-based Chem Bank has invested 0.22% in Express Scripts Holding Company (NASDAQ:ESRX). Leavell Investment Mngmt stated it has 3,039 shares. Koch has invested 0.18% in Express Scripts Holding Company (NASDAQ:ESRX). 212,300 were reported by Clough Limited Partnership. Cim Investment Mangement Inc reported 7,353 shares. Hl Financial Ltd reported 0.03% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX). Brown Advisory reported 162,224 shares stake. Johnson Financial Group Inc has invested 0.01% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX). Parsec Financial reported 15,686 shares stake. Legg Mason Asset (Japan) holds 0.57% of its portfolio in Express Scripts Holding Company (NASDAQ:ESRX) for 12,600 shares. Cs Mckee Lp holds 377,713 shares or 2.11% of its portfolio. Tiverton Asset Management Ltd Liability Corporation has 1.27% invested in Express Scripts Holding Company (NASDAQ:ESRX) for 270,958 shares.

Analysts expect Express Scripts Holding Company (NASDAQ:ESRX) to report $1.76 EPS on May, 2 after the close.They anticipate $0.43 EPS change or 32.33 % from last quarter’s $1.33 EPS. ESRX’s profit would be $988.30 million giving it 10.44 P/E if the $1.76 EPS is correct. After having $2.16 EPS previously, Express Scripts Holding Company’s analysts see -18.52 % EPS growth. The stock decreased 0.37% or $0.27 during the last trading session, reaching $73.49. About 1.80M shares traded. Express Scripts Holding Company (NASDAQ:ESRX) has risen 8.93% since April 21, 2017 and is uptrending. It has underperformed by 2.62% the S&P500.

Express Scripts Holding Company (NASDAQ:ESRX) Ratings Coverage

Among 15 analysts covering Express Scripts (NASDAQ:ESRX), 5 have Buy rating, 2 Sell and 8 Hold. Therefore 33% are positive. Express Scripts had 29 analyst reports since October 24, 2017 according to SRatingsIntel. The rating was maintained by SunTrust on Thursday, December 14 with “Buy”. On Wednesday, January 31 the stock rating was upgraded by RBC Capital Markets to “Outperform”. The firm earned “Buy” rating on Wednesday, December 20 by SunTrust. Robert W. Baird maintained the stock with “Neutral” rating in Wednesday, October 25 report. The rating was maintained by SunTrust with “Buy” on Thursday, January 11. The stock has “Underperform” rating by Bernstein on Thursday, February 1. The rating was upgraded by Bernstein on Monday, March 12 to “Market Perform”. The stock has “Hold” rating by William Blair on Thursday, March 8. The firm earned “Hold” rating on Thursday, March 8 by Mizuho. RBC Capital Markets maintained the stock with “Hold” rating in Wednesday, October 25 report.

Express Scripts Holding Company operates as a pharmacy benefit management firm in the United States, Canada, and Europe. The company has market cap of $41.27 billion. It operates in two divisions, PBM and Other Business Operations. It has a 9.49 P/E ratio. The PBM segment offers clinical solutions, specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, administration of a group purchasing organization, and consumer health and drug information services.

Express Scripts Holding Company (NASDAQ:ESRX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.